Weiss Multi Strategy Advisers LLC Global Blood Therapeutics, Inc. Transaction History

Weiss Multi Strategy Advisers LLC

$0
Q1 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $520,084 - $1.09 Million	16,052 Added 32.1%	66,052 $4.5 Million
Q2 2022 Aug 15, 2022	BUY	$22.3 - $37.39 $936,600 - $1.57 Million	42,000 Added 525.0%	50,000 $1.6 Million
Q1 2022 May 16, 2022	SELL	$25.68 - $35.59 $447,191 - $619,764	-17,414 Reduced 68.52%	8,000 $277,000
Q4 2021 Feb 14, 2022	SELL	$24.9 - $40.26 $2,589 - $4,187	-104 Reduced 0.41%	25,414 $744,000
Q3 2021 Nov 15, 2021	BUY	$25.48 - $37.34 $89,638 - $131,362	3,518 Added 15.99%	25,518 $650,000
Q2 2021 Aug 16, 2021	BUY	$32.46 - $43.42 $192,390 - $257,350	5,927 Added 36.88%	22,000 $770,000
Q1 2021 May 14, 2021	SELL	$38.94 - $50.85 $217,791 - $284,404	-5,593 Reduced 25.81%	16,073 $655,000
Q4 2020 Feb 16, 2021	SELL	$37.65 - $63.77 $389,075 - $658,999	-10,334 Reduced 32.29%	21,666 $938,000
Q3 2020 Nov 16, 2020	BUY	$52.76 - $74.49 $256,730 - $362,468	4,866 Added 17.93%	32,000 $1.76 Million
Q2 2020 Aug 14, 2020	BUY	$48.73 - $81.82 $34,988 - $58,746	718 Added 2.72%	27,134 $1.71 Million
Q1 2020 May 15, 2020	BUY	$41.72 - $87.2 $476,275 - $995,475	11,416 Added 76.11%	26,416 $1.35 Million
Q4 2019 Feb 14, 2020	BUY	$45.7 - $81.86 $228,500 - $409,300	5,000 Added 50.0%	15,000 $1.19 Million
Q3 2019 Nov 14, 2019	SELL	$45.35 - $57.91 $226,750 - $289,550	-5,000 Reduced 33.33%	10,000 $485,000
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $789,000 - $949,350	15,000 New	15,000 $789,000
Q3 2018 Nov 14, 2018	SELL	$38.0 - $51.1 $380,000 - $511,000	-10,000 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$38.7 - $50.15 $338,625 - $438,812	-8,750 Reduced 46.67%	10,000 $452,000
Q1 2018 May 15, 2018	BUY	$39.6 - $65.9 $346,500 - $576,625	8,750 Added 87.5%	18,750 $906,000
Q4 2017 Feb 14, 2018	BUY	$29.7 - $45.7 $297,000 - $457,000	10,000	10,000 $394,000

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.

Account